Envista Holdings Corp (NVST) FinancialsNVSTEnvista Holdings Corp

Envista Holdings Corporation (NVST) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Specialty Products & Technologies, accounting for 64.9% of total sales, equivalent to $457.80M. Another important revenue stream is Equipment & Consumables. Understanding this composition is critical for investors evaluating how NVST navigates market cycles within the Medical Equipment, Supplies & Distribution industry.

Evaluating the bottom line, Envista Holdings Corporation maintains a gross margin of 56.71%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 12.11%, while the net margin is 7.35%. These profitability ratios, combined with a Return on Equity (ROE) of 3.06%, provide a clear picture of how effectively NVST converts its operational activities into shareholder value.

In the context of the broader market, NVST competes directly with industry leaders such as ICUI and CELC. With a market capitalization of $4.51B, it holds a significant position in the sector. When comparing efficiency, NVST's gross margin of 56.71% stands against ICUI's 42.61% and CELC's N/A. Such benchmarking helps identify whether Envista Holdings Corporation is trading at a premium or discount relative to its financial performance.

Envista reported a strong Q2 with total revenue of $731 million and a net income of $53.7 million, reflecting a significant improvement in profitability. The gross margin for Q2 2026 was 56.71%, showing solid operational efficiency.